IFNG and neoplasm: Further immunoassay revealed that Gel@BAY simultaneously aggravates the immune resistance by upregulating the immune checkpoint PD‐L1 in both tumor cells and TAMs, which is mainly attributed to the increased secretion of inflammatory cytokine IFN‐γ.